We are live on
!
Find out more
SC
Slotnik Capital Portfolio holdings
AUM
$342M
1-Year Est. Return
105.92%
This Fund
S&P 500
This Quarter
Est. Return
+13.17%
1 Year Est. Return
+105.92%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$320M
AUM Growth
+$57.5M
(+22%)
Cap. Flow
+$41.3M
Cap. Flow
% of AUM
12.91%
Top 10 Holdings %
Top 10 Hldgs %
80.85%
Holding
42
New
21
Increased
2
Reduced
4
Closed
15
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EA
Electronic Arts
EA
|
+$34.8M |
| 2 |
Norfolk Southern
NSC
|
+$27.6M |
| 3 |
VRNA
Verona Pharma
VRNA
|
+$17.8M |
| 4 |
ARIS
Aris Water Solutions
ARIS
|
+$16.2M |
| 5 |
STAAR Surgical
STAA
|
+$15.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BPMC
Blueprint Medicines
BPMC
|
+$37.5M |
| 2 |
K
Kellanova
K
|
+$25.5M |
| 3 |
SKX
Skechers
SKX
|
+$20.5M |
| 4 |
HES
Hess
HES
|
+$13.4M |
| 5 |
GMS
GMS Inc
GMS
|
+$12M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 42.22% |
| 2 | Healthcare | 14.11% |
| 3 | Industrials | 13.69% |
| 4 | Utilities | 5.4% |
| 5 | Technology | 5.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Inhibrx
INBX
$1.3B
| $1.39M | 0.44% |
41,401
-142,770
| -78% | -$3.51M |
|
|
GES
27
DELISTED
Guess Inc
GES
| $1.34M | 0.42% |
80,202
-60,000
| -43% | -$889K |
|
|
BPMC
28
DELISTED
Blueprint Medicines
BPMC
| – | – |
-292,694
| Closed | -$37.5M |
|
|
GMS
29
CALL
DELISTED
GMS Inc
GMS
| – | – |
-131,000
| Closed | -$14.2M |
|
|
GMS
30
DELISTED
GMS Inc
GMS
| – | – |
-110,000
| Closed | -$12M |
|
|
HES
31
DELISTED
Hess
HES
| – | – |
-96,700
| Closed | -$13.4M |
|
|
INFA
32
DELISTED
Informatica
INFA
| – | – |
-334,126
| Closed | -$8.14M |
|
|
JNPR
33
DELISTED
Juniper Networks
JNPR
| – | – |
-100,000
| Closed | -$3.99M |
|
|
K
34
DELISTED
Kellanova
K
| – | – |
-321,065
| Closed | -$25.5M |
|
|
NVEE
35
DELISTED
NV5 Global
NVEE
| – | – |
-219,091
| Closed | -$5.06M |
|
36
Omnicom Group
OMC
$23.4B
| – | – |
-45,924
| Closed | -$3.3M |
|
|
RDFN
37
DELISTED
Redfin
RDFN
| – | – |
-596,600
| Closed | -$6.68M |
|
|
RDUS
38
DELISTED
Radius Recycling
RDUS
| – | – |
-238,922
| Closed | -$7.09M |
|
|
SAGE
39
DELISTED
Sage Therapeutics
SAGE
| – | – |
-166,592
| Closed | -$1.52M |
|
|
SKX
40
DELISTED
Skechers
SKX
| – | – |
-325,000
| Closed | -$20.5M |
|
|
SPTN
41
DELISTED
SpartanNash
SPTN
| – | – |
-245,000
| Closed | -$6.49M |
|
|
TIXT
42
DELISTED
TELUS International
TIXT
| – | – |
-540,776
| Closed | -$1.96M |
|
Similar funds
YCM
WPA
FCM
CWA
EC
FCM
CPI
MTIC
Slotnik Capital's Q3 2025 Portfolio in Review
As of Q3 2025, Slotnik Capital held 42 positions worth $320M, up 22% from $262M the previous quarter. Its ten largest holdings account for 81% of the portfolio.
Slotnik Capital deployed $41.3M of net new capital in Q3 2025, opening 21 new positions and adding to 2 existing holdings. Its largest new stake was Electronic Arts: 210,000 shares worth $42.4M.
By sector, the portfolio is most concentrated in Communication Services at 42% of assets, up from 33% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Inhibrx, an estimated $3.51M trimmed.
- Slotnik Capital's largest Q3 2025 buy was Electronic Arts: 210,000 shares worth $42.4M.
- Slotnik Capital added most to Liberty Broadband Class C in Q3 2025, an estimated $14.8M increase.
- Slotnik Capital's biggest Q3 2025 reduction was Inhibrx, cutting an estimated $3.51M.
- Slotnik Capital fully exited Blueprint Medicines in Q3 2025, selling an estimated $37.5M.
- Slotnik Capital's ten largest holdings make up 81% of its $320M portfolio in Q3 2025.
- Slotnik Capital opened 21 new positions and closed 15 in Q3 2025.
- Slotnik Capital's portfolio value rose 22% quarter-over-quarter to $320M.
Based on Slotnik Capital's 13F filing for Q3 2025, filed 13 Nov 2025.